Key result
A patient with Ewing's sarcoma experienced an unusually late local recurrence 18 years after inadequate initial treatment, but remained disease-free for 9 years following standard multimodal therapy.
Case Report (n=1)
No
Reports a rare case of Ewing's sarcoma with local recurrence 18 years after initial inadequate treatment, followed by 9 years of disease-free survival after standard multimodal therapy.
May warrant extended surveillance in Ewing's sarcoma survivors; leaves open optimal long-term monitoring protocols.
Here, a case of Ewing's sarcoma family of tumors (ESFT) of the femur with an unusual clinical course is reported. At 20 years of age, the patient had undergone curettage of a bone tumor of the right femur which was diagnosed as ESFT. One cycle of chemotherapy with vincristine and cyclophosphamide and radiotherapy for a total dose of 40 Gy was administered. The patient did not develop any recurrence or metastases for the following 18 years, in spite of the inadequacy of the initial treatment. At 38 years of age, he was referred to our institution with right thigh pain that had persisted for several months. Radiographs and magnetic resonance imaging findings showed a mass lesion in his proximal femur extending to the soft tissue. An open biopsy was performed and the lesion was diagnosed as recurrence of ESFT, although a molecular biological investigation did not reveal any expression of the characteristic fusion genes that have previously been reported. The patient received standard multimodal therapy employing standard combination chemo-therapy for ESFT and wide surgical excision. The patient has been disease-free for 9 years since the treatment. This patient may have a rare subtype of ESFT with an unknown chromosomal translocation and relatively non-aggressive biological behavior.
No takes yet. Share an insight, caveat, or question.
Niimi et al. (2013) conducted a case report in Ewing's sarcoma family of tumors (ESFT) (n=1). Multimodal therapy (chemotherapy and wide surgical excision) was evaluated on Disease-free survival. A patient with Ewing's sarcoma experienced an unusually late local recurrence 18 years after inadequate initial treatment, but remained disease-free for 9 years following standard multimodal therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: